WHO launches global clinical trials forum
The World Health Organization has launched the Global Clinical Trials Forum, a global, multi-stakeholder network to strengthen clinical trial environments and infrastructure at national, regional and global levels. Cochrane is pleased to be a member of this initiative.
Hear from Cochrane’s new Chief Executive Officer
In this video, Karla shares her vision for creating an evidence ecosystem that is fast, fair and fit for the future, with collaboration at the heart of this. Watch to find out more.
RSV vaccines safe and effective, Cochrane review finds
Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, a new Cochrane review has found.
Cochrane appoints Dr Karla Soares-Weiser as new Chief Executive Officer
Cochrane’s Governing Board is pleased to announce the appointment of Dr Karla Soares-Weiser as the organization’s new Chief Executive Officer.
Spotlight on Cochrane Methods Groups
Our Methods Groups provide policy advice and focus on developing the methods used to produce Cochrane reviews. Over the past year they’ve been working hard on activities from writing papers on responsible AI use to identifying research priorities.
Cochrane aligns reporting formats for diverse types of reviews
Cochrane is implementing three changes to align review reporting formats for different types of Cochrane reviews.
Heidi learned about Cochrane through her university coursework. Since then, Heidi has been involved in Cochrane Engage opportunities and beyond. Discover her story.
Reimagining evidence synthesis for a changing world
For over 30 years, the Cochrane Collaboration has set the standard for systematic reviews in health research. We now want to take evidence synthesis to the next level.
Cochrane attending the 80th United Nations General Assembly
Cochrane will be attending the 80th session of the United Nations General Assembly (UNGA), taking place in New York from the 21st to the 29th of September 2025.
New tool detects problematic trials before they distort evidence
A new tool to identify problematic trials is now available, enabling researchers to check whether studies are trustworthy before including them in systematic reviews.